Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Sampling Announcement
-
We are changing the way in which samples are going to be provided to HCPs – from hand-delivered to the use of an electronic digital sampling card that is specific to a patient. We would like to inform HCPs of this change and provide details on how the program works. There will be mention of the brand name but no claims or promotional messages. Would this email communication be considered PAAB exempt?
-
Good Morning @tmcd
No, this would not be considered exempt. It goes beyond a simple sample availability message and the communications are in reference to a service being offered for the purposes of the distribution of the brand(s). Therefore, they are subject to the advertising regulations.
